Liquid Biopsy Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Incidence of Cancer
- Increasing Research and Developments in Diagnostic Technologies
Challenges
- Changing Regulatory Standards Associated with Biopsy
- Preference for Alternative Types of Biopsy
Liquid Biopsy Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
12.3% |
|
Base Year Market Size (2024) |
USD 6.69 billion |
|
Forecast Year Market Size (2037) |
USD 30.22 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of liquid biopsy is assessed at USD 7.39 billion.
Liquid Biopsy Market size was over USD 6.69 billion in 2024 and is anticipated to cross USD 30.22 billion by 2037, growing at more than 12.3% CAGR during the forecast period i.e., between 2025-2037.
North America industry is poised to hold largest revenue share of 36% by 2037, North America industry is expected to hold largest revenue share of 36% by 2037
The major players in the market are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc., and others.
